Literature DB >> 2715202

Direct chemical measurement of the lambda of the lumped constant of the [14C]deoxyglucose method in rat brain: effects of arterial plasma glucose level on the distribution spaces of [14C]deoxyglucose and glucose and on lambda.

K Mori1, N Cruz, G Dienel, T Nelson, L Sokoloff.   

Abstract

The lumped constant in the operational equation of the 2-[14C]deoxyglucose (DG) method contains the factor lambda that represents the ratio of the steady-state tissue distribution spaces for [14C]DG and glucose. The lumped constant has been shown to vary with arterial plasma glucose concentration. Predictions based mainly on theoretical grounds have suggested that disproportionate changes in the distribution spaces for [14C]DG and glucose and in the value of lambda are responsible for these variations in the lumped constant. The influence of arterial plasma glucose concentration on the distribution spaces for DG and glucose and on lambda were, therefore, determined in the present studies by direct chemical measurements. The brain was maintained in steady states of delivery and metabolism of DG and glucose by programmed intravenous infusions of both hexoses designed to produce and maintain constant arterial concentrations. Hexose concentrations were assayed in acid extracts of arterial plasma and freeze-blown brain. Graded hyperglycemia up to 28 mM produced progressive decreases in the distribution spaces of both hexoses from their normoglycemic values (e.g., approximately -20% for glucose and -50% for DG at 28 mM). In contrast, graded hypoglycemia progressively reduced the distribution space for glucose and increased the space for [14C]DG. The values for lambda were comparatively stable in normoglycemic and hyperglycemic conditions but rose sharply (e.g., as much as 9-10-fold at 2 mM) in severe hypoglycemia.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2715202     DOI: 10.1038/jcbfm.1989.48

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  6 in total

1.  Effect of hyperglycemia on brain and liver 18F-FDG standardized uptake value (FDG SUV) measured by quantitative positron emission tomography (PET) imaging.

Authors:  Benjamin L Viglianti; Ka Kit Wong; Stephanie M Wimer; Aishwarya Parameswaran; Bin Nan; Christy Ky; Danyelle M Townsend; Domenico Rubello; Kirk A Frey; Milton D Gross
Journal:  Biomed Pharmacother       Date:  2017-02-07       Impact factor: 6.529

Review 2.  Brain injury: new insights into neurotransmitter and receptor mechanisms.

Authors:  H M Pappius
Journal:  Neurochem Res       Date:  1991-09       Impact factor: 3.996

3.  Determination of Glucose Utilization Rates in Cultured Astrocytes and Neurons with [14C]deoxyglucose: Progress, Pitfalls, and Discovery of Intracellular Glucose Compartmentation.

Authors:  Gerald A Dienel; Nancy F Cruz; Louis Sokoloff; Bernard F Driscoll
Journal:  Neurochem Res       Date:  2015-07-04       Impact factor: 3.996

4.  Metabolomic Assays of Postmortem Brain Extracts: Pitfalls in Extrapolation of Concentrations of Glucose and Amino Acids to Metabolic Dysregulation In Vivo in Neurological Diseases.

Authors:  Gerald A Dienel
Journal:  Neurochem Res       Date:  2018-08-16       Impact factor: 3.996

5.  Nimodipine does not affect the flow-metabolism couple in permanent cerebral ischemia.

Authors:  Shintaro Gomi; Mark G Burnett; Andrea Karp; Joel H Greenberg
Journal:  Exp Brain Res       Date:  2004-01-30       Impact factor: 1.972

Review 6.  Contributions of glycogen to astrocytic energetics during brain activation.

Authors:  Gerald A Dienel; Nancy F Cruz
Journal:  Metab Brain Dis       Date:  2014-02-12       Impact factor: 3.584

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.